managing transplant ineligible aml patients
Published 7 years ago • 84 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:33
sorafenib as maintenance therapy for patients with transplant-ineligible or post-allosct aml
-
4:59
frontline treatment of transplant-ineligible mm: a changing landscape
-
2:18
evolving treatment options in ndmm: transplant-eligible and transplant-ineligible patients
-
3:04
individualizing treatment in transplant-eligible & transplant-ineligible ndmm
-
7:46
updates in aml treatment and research from asco 2023
-
2:45
acute myeloid leukemia aml animation
-
2:27
predictors of outcomes in post-transplant patients with aml
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
1:44
treatment options for transplant-ineligibile hl patients
-
6:22
post-transplant maintenance for patients with aml
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
1:44
improving maintenance therapy in aml: exploring the role of idh inhibitors
-
3:57
the role of post-transplant maintenance therapy in aml
-
1:23
managing patients with multiple myeloma who have stopped treatment prior to relapse
-
2:34
the evolution of the aml treatment paradigm
-
1:26
novel transplant approaches in patients with aml
-
3:47
the role of immunotherapy in the aml treatment landscape
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more